Class I Graft-Versus-Host Mismatch Based on Predicted Indirectly Recognizable HLA Epitopes (PIRCHES) Is Associated with Worse Post-Transplant Outcomes in Patients Receiving Peripheral Blood, T-Cell Replete Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide

被引：0
|
作者：
Rimando, Joseph [1 ]
Slade, Michael [2 ]
Gao, Feng [3 ]
Romee, Rizwan [4 ,5 ]
Liu, Chang [6 ]
机构：
[1] Washington Univ, Sch Med, Dept Med, St Louis, MO USA
[2] Washington Univ, Sch Med, Div Oncol, Bone Marrow Transplantat & Leukemia Sect, St Louis, MO USA
[3] Washington Univ, Sch Med, Dept Surg, Div Publ Hlth,Sci Sect Oncol Biostat, St Louis, MO 63110 USA
[4] Dana Farber Canc Inst, Dept Hematol Malignancies, Boston, MA 02115 USA
[5] Harvard Med Sch, Boston, MA 02115 USA
[6] Washington Univ, Sch Med, Pathol & Immunol, St Louis, MO USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2019年 / 25卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
289
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Donor-specific HLA antibodies associate with chronic graft-versus-host disease in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide
    Michael Carter
    Michiko Taniguchi
    Dongyun Yang
    Shukaib Arslan
    Geoffrey Shouse
    Haris Ali
    Nicole Karras
    Ketevan Gendzekhadze
    Monzr M. Al Malki
    Bone Marrow Transplantation, 2022, 57 : 134 - 136
  • [22] Comparison of Outcomes of Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Older Versus Younger Patients
    Adoncecchi, Giacomo
    Kumar, Ambuj
    Mogili, Krishnakar
    Faramand, Rawan
    Liu, Hien
    Khimani, Farhad
    Mishra, Asmita
    Nieder, Michael
    Nishihori, Taiga
    Hansen, Doris
    Jain, Michael
    Lazaryan, Aleksandr
    Perez, Lia
    Pidala, Joseph
    Locke, Frederick
    Anasetti, Claudio
    Bejanyan, Nelli
    Elmariah, Hany
    CANCERS, 2025, 17 (02)
  • [23] Failure to Prevent Severe Graft-Versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in Chronic Granulomatous Disease
    Parta, Mark
    Hilligoss, Dianne
    Kelly, Corin
    Kwatemaa, Nana
    Theobald, Narda
    Zerbe, Christa S.
    Holland, Steven M.
    Malech, Harry L.
    Kang, Elizabeth M.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2020, 40 (04) : 619 - 624
  • [24] Risk Factors for Graft-Versus-Host Disease (GVHD) in Haploidentical Hematopoietic Cell Transplantation (HCT) Using Post-Transplant Cyclophosphamide (PTCy)
    Rashidi, Armin
    Hamilton, Betty K.
    Wang, Tao
    Hemmer, Michael T.
    Spellman, Stephen R.
    Alousi, Amin M.
    Jagasia, Madan
    Pidala, Joseph A.
    Arora, Mukta
    Im, Annie P.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [25] Failure to Prevent Severe Graft-Versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in Chronic Granulomatous Disease
    Mark Parta
    Dianne Hilligoss
    Corin Kelly
    Nana Kwatemaa
    Narda Theobald
    Christa S. Zerbe
    Steven M. Holland
    Harry L. Malech
    Elizabeth M. Kang
    Journal of Clinical Immunology, 2020, 40 : 619 - 624
  • [26] Reconstitution of cellular immunity after T-cell replete haploidentical stem cell transplantation by use of post-transplant cyclophosphamide
    Tsonis, I.
    Baltadakis, I.
    Vardaka, M.
    Oikonomopoulou, D.
    Giatra, C.
    Vasileiou, S.
    Tzenou, T.
    Grispou, E.
    Karatza, M.
    Bika, E.
    Poulopoulou, Z.
    Delistrati, V.
    Gigantes, S.
    Harhalakis, N.
    Karakasis, D.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S347 - S348
  • [27] Sirolimus and Post-Transplant Cyclophosphamide as Graft-versus-Host Prophylaxis in Patients Undergoing Matched Allogeneic Peripheral Blood Stem Cell Transplantation
    Ulrickson, Matthew
    Damghani, Faraz
    Yancey, Kristina
    Mohammed, Reeshma
    Davies, Kayla
    Rangan, Pooja
    De Padova, Nicolas
    Go, Aileen
    Kodali, Murali
    Nath, Rajneesh
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S450 - S451
  • [28] Peripheral Blood Stem Cells versus Bone Marrow for T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Hodgkin Lymphoma
    Mariotti, Jacopo
    Devillier, Raynier
    Bramanti, Stefania
    Giordano, Laura
    Sarina, Barbara
    Furst, Sabine
    Granata, Angela
    Maisano, Valerio
    Pagliardini, Thomas
    De Philippis, Chiara
    Kogan, Maria
    Faucher, Catherine
    Harbi, Samia
    Chabannon, Christian
    Carlo-Stella, Carmelo
    Bouabdallah, Reda
    Santoro, Armando
    Blaise, Didier
    Castagna, Luca
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (09) : 1810 - 1817
  • [29] Viral Reactivation after T-Cell Replete Haploidentical Transplantation Using Myeloablative Conditioning and Post-Transplant Cyclophosphamide
    Bezerra, Evandro
    da Silva, Roberto Luiz
    Schmidt Filho, Jayr
    Santos, Marina
    Nascimento, Marina
    Simoes, Aline
    Xavier, Erick
    Almeida, Manuella
    Mariano, Livia Caroline
    Fernandes, Pedro
    Marques, Larissa
    Costa, Sylvia
    Seber, Adriana
    Macedo, Maria Cristina
    Machado, Clarisse
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S366 - S367
  • [30] T-Cell Replete Haploidentical PBSC Transplantation Using Intensified Myeloablative Conditioning, Post-Transplant Cyclophosphamide and Sirolimus
    Greco, R.
    Piemontese, S.
    Cieri, N.
    Giglio, F.
    Morelli, M.
    Messina, C.
    Marcatti, M.
    Marktel, S.
    Carrabba, M.
    Bernardi, M.
    Corti, C.
    Assanelli, A.
    Stanghellini, M. T. Lupo
    Bonini, C.
    Vago, L.
    Ciceri, F.
    Peccatori, J.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S355 - S356
12345